ALERT CONTENT PLACEHOLDER
Interferon Lambda with Dr. Jordan Feld

Air Date: November 9, 2021 | Length: 53:10

Apple Podcast logo  
Google Play  
Podbean logo​​​​
Transcript logo
Dr. Jordan Feld

Share this episode: link to UHN Twitter link to UHN Facebook link to UHN LinkedIn

Episode Description

The COVID-19 pandemic shocked everyone around the world - even those who study viruses such as Dr. Jordan Feld. In 2015, Dr. Feld led a groundbreaking international trial that made the breakthrough discovery of a pill that cures Hepatitis C. When the pandemic hit, he shifted gears and led another pioneering investigation into a treatment for the Coronavirus using Interferon Lambda. After a successful phase one and two trial, it is currently in phase three with more patients enrolled.

Compounding the urgency for COVID-19 treatments, Dr. Feld was juggling the approval process for his trial with the birth of his third son. He touches on the impact the pandemic had on research, how his team maintained a safe environment during the trial and what it means to be a mentor.

About Dr. Jordan Feld

Dr. Jordan Feld is trained in Gastroenterology and Hepatology at the University of Toronto and did post-doctoral training in the Liver Diseases Branch at the National Institutes of Health in laboratory and clinical research in viral hepatitis. After completing a Masters in Public Health at the Johns Hopkins Bloomberg School of Public Health, he returned to Toronto. He is a Professor of Medicine at the University of Toronto and holds the R. Phelan Chair in Translational Liver Research as a clinician-scientist at the Toronto Centre for Liver Disease in the Toronto General Hospital where he leads a large clinical and translational research program focused primarily on viral hepatitis and its complications.

Quicklinks
Back to Top